ATE539170T1 - Abschätzung und verringerung des risikos von graft-versus-host-reaktion - Google Patents
Abschätzung und verringerung des risikos von graft-versus-host-reaktionInfo
- Publication number
- ATE539170T1 ATE539170T1 AT07719640T AT07719640T ATE539170T1 AT E539170 T1 ATE539170 T1 AT E539170T1 AT 07719640 T AT07719640 T AT 07719640T AT 07719640 T AT07719640 T AT 07719640T AT E539170 T1 ATE539170 T1 AT E539170T1
- Authority
- AT
- Austria
- Prior art keywords
- assessing
- versus host
- graft versus
- risk
- reducing
- Prior art date
Links
- 208000024908 graft versus host disease Diseases 0.000 title abstract 3
- 208000009329 Graft vs Host Disease Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000011223 gene expression profiling Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
- G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74576106P | 2006-04-27 | 2006-04-27 | |
| PCT/CA2007/000714 WO2007124578A1 (en) | 2006-04-27 | 2007-04-27 | Assessment and reduction of risk of graft-versus-host disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE539170T1 true ATE539170T1 (de) | 2012-01-15 |
Family
ID=38655008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07719640T ATE539170T1 (de) | 2006-04-27 | 2007-04-27 | Abschätzung und verringerung des risikos von graft-versus-host-reaktion |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US7763425B2 (de) |
| EP (1) | EP2021534B1 (de) |
| JP (1) | JP5171812B2 (de) |
| AT (1) | ATE539170T1 (de) |
| CA (1) | CA2650507A1 (de) |
| WO (1) | WO2007124578A1 (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005070086A2 (en) | 2004-01-21 | 2005-08-04 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for determining a graft tolerant phenotype in a subject |
| EP2604703B1 (de) | 2005-03-14 | 2017-02-01 | The Board of Trustees of the Leland Stanford Junior University | Verfahren zur Bewertung der Haltbarkeit eines Pfropfs im Körper eines Empfängers fester Organtransplantate |
| USRE46843E1 (en) | 2005-03-14 | 2018-05-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for evaluating graft survival in a solid organ transplant recipient |
| WO2009075811A1 (en) * | 2007-12-07 | 2009-06-18 | Tufts Medical Center, Inc. | Compositions and methods for immortalizing cells and screening for anti-cancer agents |
| CA2712773A1 (en) * | 2008-01-22 | 2009-07-30 | Veridex, Llc | Molecular staging of stage ii and iii colon cancer and prognosis |
| WO2010021696A1 (en) * | 2008-08-18 | 2010-02-25 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for determining a graft tolerant phenotype in a subject |
| ES2492498T3 (es) | 2009-01-15 | 2014-09-09 | The Board Of Trustees Of The Leland Stanford Junior University | Panel de biomarcadores para el diagnóstico y la predicción de rechazo de injerto |
| WO2010096160A1 (en) * | 2009-02-17 | 2010-08-26 | The Board Of Trustees Of The Leland Stanford Junior University | Compartment-specific non-hla targets for diagnosis and prediction of graft outcome |
| GB0917457D0 (en) * | 2009-10-06 | 2009-11-18 | Glaxosmithkline Biolog Sa | Method |
| EP2507630B1 (de) | 2009-12-02 | 2017-01-25 | The Board of Trustees of The Leland Stanford Junior University | Biomarker zur bestimmung eines allotransplantattoleranten phänotyps |
| IT1397083B1 (it) * | 2009-12-04 | 2012-12-28 | Biouniversa Srl | Marcatore biochimico serico |
| WO2011119980A1 (en) | 2010-03-25 | 2011-09-29 | The Board Of Trustees Of The Leland Stanford Junior University | Protein and gene biomarkers for rejection of organ transplants |
| US20120277999A1 (en) * | 2010-10-29 | 2012-11-01 | Pbd Biodiagnostics, Llc | Methods, kits and arrays for screening for, predicting and identifying donors for hematopoietic cell transplantation, and predicting risk of hematopoietic cell transplant (hct) to induce graft vs. host disease (gvhd) |
| KR20130132904A (ko) * | 2010-12-06 | 2013-12-05 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 인간 모노클로날 항체 |
| US8440797B2 (en) | 2010-12-06 | 2013-05-14 | Dainippon Sumitomo Pharma Co., Ltd. | Human monoclonal antibody |
| GB201021149D0 (en) * | 2010-12-14 | 2011-01-26 | Georg August Uni Gottingen Stiftung Offentlichen Rechts | Use of a skin explant assay for mRNA expression analysis for the identification of new genes and drug targets associated with graft versus host disease |
| US8962261B2 (en) | 2011-04-06 | 2015-02-24 | The Board Of Trustees Of The Leland Stanford Junior University | Autoantibody biomarkers for IGA nephropathy |
| US10385475B2 (en) | 2011-09-12 | 2019-08-20 | Adaptive Biotechnologies Corp. | Random array sequencing of low-complexity libraries |
| ES2769270T3 (es) | 2011-09-30 | 2020-06-25 | Bluebird Bio Inc | Compuestos para transducción viral mejorada |
| JP5904801B2 (ja) * | 2012-01-17 | 2016-04-20 | シスメックス株式会社 | 制御性ｔ細胞への分化誘導能の予測方法及びその方法に用いられるバイオマーカー、並びにそれらの利用 |
| WO2014055687A1 (en) * | 2012-10-05 | 2014-04-10 | Hitachi Chemical Co., Ltd. | Urine exosome mrnas and methods of using same to detect diabetic nephropathy |
| WO2014182330A1 (en) | 2013-05-06 | 2014-11-13 | Hitachi Chemical Company Ltd | Devices and methods for capturing target molecules |
| WO2014189635A1 (en) * | 2013-05-20 | 2014-11-27 | The Trustees Of Columbia University In The City Of New York | Tracking donor-reactive tcr as a biomarker in transplantation |
| JP2017521801A (ja) | 2014-05-07 | 2017-08-03 | ピルヒェ アーゲー | 移植におけるアロ反応性を予測する方法及びシステム |
| US10266895B2 (en) | 2014-11-05 | 2019-04-23 | Hitachi Chemical Company Ltd. | Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease |
| EP3218521B1 (de) | 2014-11-12 | 2019-12-25 | Hitachi Chemical Co., Ltd. | Verfahren zur diagnose von organverletzung |
| US9563744B1 (en) * | 2014-12-03 | 2017-02-07 | Biodesix, Inc. | Method of predicting development and severity of graft-versus-host disease |
| CN104878099B (zh) * | 2015-05-15 | 2018-02-16 | 西北农林科技大学 | 山羊atbf1基因单核苷酸多态性的检测方法及其应用 |
| DE112016003948T5 (de) | 2015-08-31 | 2018-05-09 | City Of Sapporo | Molekulare verfahren zum beurteilen einer urothelialen erkrankung |
| IL261002B2 (en) | 2016-02-12 | 2024-07-01 | Bluebird Bio Inc | Vcn enhancer compositions and methods of using the same |
| TW201837467A (zh) | 2017-03-01 | 2018-10-16 | 美商建南德克公司 | 用於癌症之診斷及治療方法 |
| JP2020526218A (ja) | 2017-07-14 | 2020-08-31 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 移植拒絶リスクを予測する新規の方法 |
| JPWO2020158832A1 (de) * | 2019-01-30 | 2020-08-06 | ||
| SG11202112347RA (en) * | 2019-05-23 | 2021-12-30 | Spacecraft Seven Llc | Gene therapy vectors for infantile malignant osteopetrosis |
| KR20250012749A (ko) * | 2022-04-22 | 2025-01-24 | 스페이스크래프트 세븐, 엘엘씨 | Aav 벡터를 사용한 b-세포 림프종 2-관련 안타노겐 3(bag3) 유전자 요법 |
| WO2024151826A1 (en) * | 2023-01-12 | 2024-07-18 | Jasper Therapeutics, Inc. | Methods for the prevention and treatment of gvhd |
| WO2025259362A1 (en) * | 2024-06-12 | 2025-12-18 | The Board Of Trustees Of The Leland Stanford Junior University | Enhancements for proximal signaling car activation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1334113A4 (de) | 2000-10-20 | 2007-08-08 | Expression Diagnostics Inc | Erstellen von leukozytenexpressionsprofilen |
| US7235358B2 (en) * | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US20060099591A1 (en) * | 2002-08-22 | 2006-05-11 | Andreas Krause | Diagnosis of chronic rejection |
| WO2005054503A2 (en) * | 2003-12-03 | 2005-06-16 | Novartis Ag | Biomarkers for graft rejection |
| US8053182B2 (en) * | 2004-01-30 | 2011-11-08 | The Trustees Of The University Of Pennsylvania | Predictors of transplant rejection determined by peripheral blood gene-expression profiling |
-
2007
- 2007-04-27 CA CA002650507A patent/CA2650507A1/en not_active Abandoned
- 2007-04-27 AT AT07719640T patent/ATE539170T1/de active
- 2007-04-27 WO PCT/CA2007/000714 patent/WO2007124578A1/en not_active Ceased
- 2007-04-27 US US11/741,492 patent/US7763425B2/en not_active Expired - Fee Related
- 2007-04-27 JP JP2009506882A patent/JP5171812B2/ja not_active Expired - Fee Related
- 2007-04-27 EP EP07719640A patent/EP2021534B1/de not_active Not-in-force
-
2010
- 2010-06-11 US US12/814,271 patent/US20100248254A1/en not_active Abandoned
-
2012
- 2012-11-20 US US13/682,303 patent/US9102981B2/en not_active Expired - Fee Related
-
2015
- 2015-06-30 US US14/755,956 patent/US20150337374A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP5171812B2 (ja) | 2013-03-27 |
| EP2021534A1 (de) | 2009-02-11 |
| WO2007124578A1 (en) | 2007-11-08 |
| EP2021534B1 (de) | 2011-12-28 |
| EP2021534A4 (de) | 2009-11-11 |
| US20130324427A1 (en) | 2013-12-05 |
| JP2009538599A (ja) | 2009-11-12 |
| US20070264272A1 (en) | 2007-11-15 |
| US9102981B2 (en) | 2015-08-11 |
| US7763425B2 (en) | 2010-07-27 |
| CA2650507A1 (en) | 2007-11-08 |
| US20150337374A1 (en) | 2015-11-26 |
| US20100248254A1 (en) | 2010-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE539170T1 (de) | Abschätzung und verringerung des risikos von graft-versus-host-reaktion | |
| NO20090047L (no) | Anti-DLL4-antistoffer og fremgangsmater for anvendelse av disse | |
| ATE514755T1 (de) | Fluoreszenzfarbstoffe zur verwendung bei der glukoseerfassung | |
| EA200900781A1 (ru) | 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды | |
| NO20083397L (no) | Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse | |
| ATE517992T1 (de) | Funktionelle und hyperfunktionelle sirna | |
| TW200621253A (en) | 2-amido-thiazole-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof | |
| ATE544774T1 (de) | Rnai-modulation von mll-af4 und verwendungen dafür | |
| WO2006063042A3 (en) | Selecting patients for therapy with a her inhibitor | |
| DK1737974T3 (da) | Fremgangsmåder til identifikation af proteiner med stivelsesphosphorylerende enzymatisk aktivitet | |
| NO20082386L (no) | Ligander som har bindingsspesifisitet for EGFR og/eller VEGF og fremgangsmater for anvendelse derav | |
| WO2005082341A3 (en) | NON-PEPTIDYL AGENTS WITH pHSP20-LIKE ACTIVITY, AND USES THEREOF | |
| CY1111151T1 (el) | Αναστολεις φωσφολιπασης α2 του κυτταροδιαλυματος | |
| DK2089516T3 (da) | Fremgangsmåder til at forbedre indføringen af DNA i bakterielle celler | |
| DE602007002568D1 (de) | Chloramphenicolresistenz-selektion bei bacillus licheniformis | |
| WO2007047408A3 (en) | Promac signature application | |
| DE602007000894D1 (de) | Verstärkte Reaktivierung wärmebeständiger, reversibel inaktivierter Enzyme | |
| WO2007039290A3 (en) | Methods and nucleic acids for the analysis of gene expression associated with the prognosis of cell proliferative disorders | |
| NO20083593L (no) | Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse | |
| CO6241120A2 (es) | (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS. | |
| ATE452149T1 (de) | Modifizierte polyolefinwachse | |
| ATE513929T1 (de) | Gene mit einfluss auf die menschliche gedächtnisleistung | |
| CY1116649T1 (el) | Τεχνητη dna αλληλουχια με βελτιστοποιημενη λειτουργια οδηγου σε 5' (5-utr) για βελτιωμενη εκφραση ετερολογων πρωτεϊνων σε φυτα | |
| EA200702193A1 (ru) | Гликозилирование белков | |
| ITMO20030081A0 (it) | Bioreattore,particolarmente per organi bioartificiali. |